Literature DB >> 11696382

Immunity induced shortly after DNA vaccination of rainbow trout against rhabdoviruses protects against heterologous virus but not against bacterial pathogens.

Niels Lorenzen1, Ellen Lorenzen, Katja Einer-Jensen, Scott E LaPatra.   

Abstract

It was recently reported that DNA vaccination of rainbow trout fingerlings against viral hemorrhagic septicaemia virus (VHSV) induced protection within 8 days after intramuscular injection of plasmid DNA. In order to analyse the specificity of this early immunity, fish were vaccinated with plasmid DNA encoding the VHSV or the infectious haematopoietic necrosis virus (IHNV) glycoprotein genes and later challenged with homologous or heterologous pathogens. Challenge experiments revealed that immunity established shortly after vaccination was cross-protective between the two viral pathogens whereas no increased survival was found upon challenge with bacterial pathogens. Within two months after vaccination, the cross-protection disappeared while the specific immunity to homologous virus remained high. The early immunity induced by the DNA vaccines thus appeared to involve short-lived non-specific anti-viral defence mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11696382     DOI: 10.1016/s0145-305x(01)00059-3

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  21 in total

Review 1.  Fish can be first--advances in fish transgenesis for commercial applications.

Authors:  Halina M Zbikowska
Journal:  Transgenic Res       Date:  2003-08       Impact factor: 2.788

2.  Analysis of DNA-vaccinated fish reveals viral antigen in muscle, kidney and thymus, and transient histopathologic changes.

Authors:  Kyle A Garver; Carla M Conway; Diane G Elliott; Gael Kurath
Journal:  Mar Biotechnol (NY)       Date:  2005-07-22       Impact factor: 3.619

Review 3.  Immunological control of fish diseases.

Authors:  Bergljot Magnadottir
Journal:  Mar Biotechnol (NY)       Date:  2010-03-30       Impact factor: 3.619

4.  Inhibition of an Aquatic Rhabdovirus Demonstrates Promise of a Broad-Spectrum Antiviral for Use in Aquaculture.

Authors:  Bethany F Balmer; Rachel L Powers; Ting-Hu Zhang; Jihye Lee; Frederic Vigant; Benhur Lee; Michael E Jung; Maureen K Purcell; Kevin Snekvik; Hector C Aguilar
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

5.  Pepscan mapping of viral hemorrhagic septicemia virus glycoprotein G major lineal determinants implicated in triggering host cell antiviral responses mediated by type I interferon.

Authors:  V Chico; A Martinez-Lopez; M Ortega-Villaizan; A Falco; L Perez; J M Coll; A Estepa
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

6.  CpG DNA induces protective antiviral immune responses in Atlantic salmon (Salmo salar L.).

Authors:  Jorunn B Jørgensen; Lill-Heidi Johansen; Kari Steiro; Audny Johansen
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

7.  Microarray-based identification of differentially expressed genes in families of turbot (Scophthalmus maximus) after infection with viral haemorrhagic septicaemia virus (VHSV).

Authors:  P Díaz-Rosales; A Romero; P Balseiro; S Dios; B Novoa; A Figueras
Journal:  Mar Biotechnol (NY)       Date:  2012-07-13       Impact factor: 3.619

8.  Towards a metalloprotease-DNA vaccine against piscine cryptobiosis caused by Cryptobia salmositica.

Authors:  Chung-Wei Tan; Palmy Jesudhasan; Patrick T K Woo
Journal:  Parasitol Res       Date:  2007-10-12       Impact factor: 2.289

Review 9.  DNA vaccines in veterinary use.

Authors:  Laurel Redding; David B Weiner
Journal:  Expert Rev Vaccines       Date:  2009-09       Impact factor: 5.217

10.  Approaches towards DNA vaccination against a skin ciliate parasite in fish.

Authors:  Louise von Gersdorff Jørgensen; Jens Sigh; Per Walter Kania; Lars Holten-Andersen; Kurt Buchmann; Theodore Clark; Jesper Skou Rasmussen; Katja Einer-Jensen; Niels Lorenzen
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.